Skip to main content
Top
Published in: BMC Medicine 1/2018

Open Access 01-12-2018 | Research article

Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis

Authors: Joshua L. Warren, Louis Grandjean, David A. J. Moore, Anna Lithgow, Jorge Coronel, Patricia Sheen, Jonathan L. Zelner, Jason R. Andrews, Ted Cohen

Published in: BMC Medicine | Issue 1/2018

Login to get access

Abstract

Background

Congregate settings may serve as institutional amplifiers of tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB). We analyze spatial, epidemiological, and pathogen genetic data prospectively collected from neighborhoods surrounding a prison in Lima, Peru, where inmates experience a high risk of MDR-TB, to investigate the risk of spillover into the surrounding community.

Methods

Using hierarchical Bayesian statistical modeling, we address three questions regarding the MDR-TB risk: (i) Does the excess risk observed among prisoners also extend outside the prison? (ii) If so, what is the magnitude, shape, and spatial range of this spillover effect? (iii) Is there evidence of additional transmission across the region?

Results

The region of spillover risk extends for 5.47 km outside of the prison (95% credible interval: 1.38, 9.63 km). Within this spillover region, we find that nine of the 467 non-inmate patients (35 with MDR-TB) have MDR-TB strains that are genetic matches to strains collected from current inmates with MDR-TB, compared to seven out of 1080 patients (89 with MDR-TB) outside the spillover region (p values: 0.022 and 0.008). We also identify eight spatially aggregated genetic clusters of MDR-TB, four within the spillover region, consistent with local transmission among individuals living close to the prison.

Conclusions

We demonstrate a clear prison spillover effect in this population, which suggests that interventions in the prison may have benefits that extend to the surrounding community.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300.CrossRefPubMedPubMedCentral Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300.CrossRefPubMedPubMedCentral
3.
go back to reference Dheda K, Limberis JD, Pietersen E, Phelan J, Esmail A, Lesosky M, Fennelly KP, te Riele J, Mastrapa B, Streicher EM. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir Med. 2017;5(4):269–81.CrossRefPubMed Dheda K, Limberis JD, Pietersen E, Phelan J, Esmail A, Lesosky M, Fennelly KP, te Riele J, Mastrapa B, Streicher EM. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir Med. 2017;5(4):269–81.CrossRefPubMed
4.
go back to reference Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, Van Soolingen D, Jensen P, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–43.CrossRefPubMed Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, Van Soolingen D, Jensen P, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–43.CrossRefPubMed
5.
go back to reference Cohen T, Jenkins HE, Lu C, McLaughlin M, Floyd K, Zignol M. On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data. Drug Resist Updat. 2014;17(4):105–23.CrossRefPubMedPubMedCentral Cohen T, Jenkins HE, Lu C, McLaughlin M, Floyd K, Zignol M. On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data. Drug Resist Updat. 2014;17(4):105–23.CrossRefPubMedPubMedCentral
6.
go back to reference Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med. 2015;3(12):963–72.CrossRefPubMedPubMedCentral Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med. 2015;3(12):963–72.CrossRefPubMedPubMedCentral
7.
go back to reference Basu S, Stuckler D, McKee M. Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics. Am J Trop Med Hyg. 2011;84(1):30–7.CrossRefPubMedPubMedCentral Basu S, Stuckler D, McKee M. Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics. Am J Trop Med Hyg. 2011;84(1):30–7.CrossRefPubMedPubMedCentral
8.
go back to reference Yates T, Tanser F, Abubakar I. Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings. Int J Tuberc Lung Dis. 2016;20(1):5–10.CrossRefPubMedPubMedCentral Yates T, Tanser F, Abubakar I. Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings. Int J Tuberc Lung Dis. 2016;20(1):5–10.CrossRefPubMedPubMedCentral
9.
go back to reference Biadglegne F, Rodloff A, Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 2015;143(5):887–900.CrossRefPubMed Biadglegne F, Rodloff A, Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 2015;143(5):887–900.CrossRefPubMed
10.
go back to reference Nardell E, Dharmadhikari A. Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis. 2010;14(10):1233–43.PubMedPubMedCentral Nardell E, Dharmadhikari A. Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis. 2010;14(10):1233–43.PubMedPubMedCentral
11.
go back to reference Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005;60(2):130–5.CrossRefPubMedPubMedCentral Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005;60(2):130–5.CrossRefPubMedPubMedCentral
12.
go back to reference Shah L, Choi H, Berrang-Ford L, Henostroza G, Krapp F, Zamudio C, Heymann S, Kaufman J, Ciampi A, Seas C. Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru. Int J Tuberc Lung Dis. 2014;18(11):1307–14.CrossRefPubMed Shah L, Choi H, Berrang-Ford L, Henostroza G, Krapp F, Zamudio C, Heymann S, Kaufman J, Ciampi A, Seas C. Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru. Int J Tuberc Lung Dis. 2014;18(11):1307–14.CrossRefPubMed
13.
go back to reference Umubyeyi A, Shamputa IC, Rigouts L, Dediste A, Struelens M, Portaels F. Evidence of ‘amplifier effect’ in pulmonary multidrug-resistant tuberculosis: report of three cases. Int J Infect Dis. 2007;11(6):508–12.CrossRefPubMed Umubyeyi A, Shamputa IC, Rigouts L, Dediste A, Struelens M, Portaels F. Evidence of ‘amplifier effect’ in pulmonary multidrug-resistant tuberculosis: report of three cases. Int J Infect Dis. 2007;11(6):508–12.CrossRefPubMed
14.
15.
go back to reference Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci. 2008;105(36):13280–5.CrossRefPubMed Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci. 2008;105(36):13280–5.CrossRefPubMed
16.
go back to reference Sacchi FP, Praça RM, Tatara MB, Simonsen V, Ferrazoli L, Croda MG, Suffys PN, Ko AI, Andrews JR, Croda J. Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg Infect Dis. 2015;21(3):452–5.CrossRefPubMedPubMedCentral Sacchi FP, Praça RM, Tatara MB, Simonsen V, Ferrazoli L, Croda MG, Suffys PN, Ko AI, Andrews JR, Croda J. Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg Infect Dis. 2015;21(3):452–5.CrossRefPubMedPubMedCentral
17.
go back to reference Jones TF, Woodley CL, Fountain FF, Schaffner W. Increased incidence of the outbreak strain of Mycobacterium tuberculosis in the surrounding community after an outbreak in a jail. South Med J. 2003;96(2):155–7.CrossRefPubMed Jones TF, Woodley CL, Fountain FF, Schaffner W. Increased incidence of the outbreak strain of Mycobacterium tuberculosis in the surrounding community after an outbreak in a jail. South Med J. 2003;96(2):155–7.CrossRefPubMed
18.
go back to reference Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J. 2013;42(5):1291–301.CrossRefPubMed Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J. 2013;42(5):1291–301.CrossRefPubMed
19.
go back to reference Grandjean L, Iwamoto T, Lithgow A, Gilman RH, Arikawa K, Nakanishi N, Martin L, Castillo E, Alarcon V, Coronel J. The association between Mycobacterium tuberculosis genotype and drug resistance in Peru. PLoS One. 2015;10(5):e0126271.CrossRefPubMedPubMedCentral Grandjean L, Iwamoto T, Lithgow A, Gilman RH, Arikawa K, Nakanishi N, Martin L, Castillo E, Alarcon V, Coronel J. The association between Mycobacterium tuberculosis genotype and drug resistance in Peru. PLoS One. 2015;10(5):e0126271.CrossRefPubMedPubMedCentral
20.
go back to reference Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498–510.CrossRefPubMedPubMedCentral Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498–510.CrossRefPubMedPubMedCentral
21.
go back to reference Watanabe S. Asymptotic equivalence of Bayes cross validation and widely applicable information criterion in singular learning theory. J Mach Learn Res. 2010;11(Dec):3571–94. Watanabe S. Asymptotic equivalence of Bayes cross validation and widely applicable information criterion in singular learning theory. J Mach Learn Res. 2010;11(Dec):3571–94.
22.
go back to reference Vehtari A, Gelman A, Gabry J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat Comput. 2017;27(5):1413–32.CrossRef Vehtari A, Gelman A, Gabry J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat Comput. 2017;27(5):1413–32.CrossRef
23.
go back to reference Gelfand AE, Ghosh SK. Model choice: a minimum posterior predictive loss approach. Biometrika. 1998;85(1):1–11.CrossRef Gelfand AE, Ghosh SK. Model choice: a minimum posterior predictive loss approach. Biometrika. 1998;85(1):1–11.CrossRef
24.
go back to reference Warren JL, Mwanza J-C, Tanna AP, Budenz DL. A statistical model to analyze clinician expert consensus on glaucoma progression using spatially correlated visual field data. Transl Vis Sci Technol. 2016;5(4):14.CrossRefPubMedPubMedCentral Warren JL, Mwanza J-C, Tanna AP, Budenz DL. A statistical model to analyze clinician expert consensus on glaucoma progression using spatially correlated visual field data. Transl Vis Sci Technol. 2016;5(4):14.CrossRefPubMedPubMedCentral
25.
go back to reference Banerjee S, Carlin BP, Gelfand AE. Hierarchical modeling and analysis for spatial data. Boca Raton: CRC Press; 2014. Banerjee S, Carlin BP, Gelfand AE. Hierarchical modeling and analysis for spatial data. Boca Raton: CRC Press; 2014.
26.
go back to reference R Core Team. R: a language and environment for statistical computing. In: R Foundation for Statistical Computing; 2016. R Core Team. R: a language and environment for statistical computing. In: R Foundation for Statistical Computing; 2016.
27.
go back to reference Geweke J. Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments, vol. 196. Minneapolis: Federal Reserve Bank of Minneapolis, Research Department; 1991. Geweke J. Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments, vol. 196. Minneapolis: Federal Reserve Bank of Minneapolis, Research Department; 1991.
28.
go back to reference Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerg Infect Dis. 2011;17(6):969–75.CrossRefPubMedPubMedCentral Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerg Infect Dis. 2011;17(6):969–75.CrossRefPubMedPubMedCentral
29.
go back to reference Pybus OG, Suchard MA, Lemey P, Bernardin FJ, Rambaut A, Crawford FW, Gray RR, Arinaminpathy N, Stramer SL, Busch MP. Unifying the spatial epidemiology and molecular evolution of emerging epidemics. Proc Natl Acad Sci. 2012;109(37):15066–71.CrossRefPubMed Pybus OG, Suchard MA, Lemey P, Bernardin FJ, Rambaut A, Crawford FW, Gray RR, Arinaminpathy N, Stramer SL, Busch MP. Unifying the spatial epidemiology and molecular evolution of emerging epidemics. Proc Natl Acad Sci. 2012;109(37):15066–71.CrossRefPubMed
30.
go back to reference Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang ZB, Manjourides J, et al. Identifying hotspots of multidrug-resistant tuberculosis transmission using spatial and molecular genetic data. J Infect Dis. 2016;213(2):287–94.CrossRefPubMed Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang ZB, Manjourides J, et al. Identifying hotspots of multidrug-resistant tuberculosis transmission using spatial and molecular genetic data. J Infect Dis. 2016;213(2):287–94.CrossRefPubMed
31.
go back to reference Shah NS, Auld SC, Brust JC, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T. Transmission of extensively drug-resistant tuberculosis in South Africa. N Engl J Med. 2017;376(3):243–53.CrossRefPubMedPubMedCentral Shah NS, Auld SC, Brust JC, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T. Transmission of extensively drug-resistant tuberculosis in South Africa. N Engl J Med. 2017;376(3):243–53.CrossRefPubMedPubMedCentral
34.
go back to reference Roetzer A, Diel R, Kohl TA, Rückert C, Nübel U, Blom J, Wirth T, Jaenicke S, Schuback S, Rüsch-Gerdes S. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med. 2013;10(2):e1001387.CrossRefPubMedPubMedCentral Roetzer A, Diel R, Kohl TA, Rückert C, Nübel U, Blom J, Wirth T, Jaenicke S, Schuback S, Rüsch-Gerdes S. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med. 2013;10(2):e1001387.CrossRefPubMedPubMedCentral
35.
go back to reference Didelot X, Gardy J, Colijn C. Bayesian inference of infectious disease transmission from whole-genome sequence data. Mol Biol Evol. 2014;31(7):1869–79.CrossRefPubMedPubMedCentral Didelot X, Gardy J, Colijn C. Bayesian inference of infectious disease transmission from whole-genome sequence data. Mol Biol Evol. 2014;31(7):1869–79.CrossRefPubMedPubMedCentral
Metadata
Title
Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis
Authors
Joshua L. Warren
Louis Grandjean
David A. J. Moore
Anna Lithgow
Jorge Coronel
Patricia Sheen
Jonathan L. Zelner
Jason R. Andrews
Ted Cohen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2018
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-018-1111-x

Other articles of this Issue 1/2018

BMC Medicine 1/2018 Go to the issue